Y-Intercept (HK)’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.03M Buy
45,586
+29,945
+191% +$2.93M 0.09% 309
2026
Q2
$1.41M Buy
+15,641
New +$1.33M 0.03% 885
2026
Q1
– Sell
-42,019
Closed -$3.85M – 1775
2025
Q4
$3.85M Buy
+42,019
New +$4.02M 0.09% 320
2024
Q1
– Sell
-4,976
Closed -$330K – 1538
2023
Q4
$330K Buy
+4,976
New +$345K 0.03% 778
2023
Q3
– Sell
-5,286
Closed -$334K – 1271
2023
Q2
$334K Buy
+5,286
New +$307K 0.04% 729
2023
Q1
– Sell
-9,564
Closed -$590K – 1327
2022
Q4
$590K Buy
+9,564
New +$643K 0.09% 374

Other funds holding HQY

Y-Intercept (HK)'s HQY Position: Q3 2026 in Review

Y-Intercept (HK) increased its HealthEquity (HQY) stake by 191% in Q3 2026, buying an estimated $2.93M and bringing the position to 45,586 shares worth $4.03M. The position accounts for 0.09% of the portfolio, ranked #309.

Y-Intercept (HK) first reported a position in HQY in Q4 2022 and has held it in 6 quarters since. 280 funds tracked by Wall St. Rank hold HQY as of Q3 2026.

  • Y-Intercept (HK) held 45,586 shares of HealthEquity worth $4.03M as of Q3 2026.
  • Y-Intercept (HK) bought 29,945 HealthEquity shares in Q3 2026, an estimated $2.93M.
  • HealthEquity made up 0.09% of Y-Intercept (HK)'s portfolio in Q3 2026, its #309 holding.
  • Y-Intercept (HK) first reported a position in HealthEquity in Q4 2022 and has held it in 6 quarters since.
  • 280 funds tracked by Wall St. Rank held HealthEquity as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.